About ANIX

ITUS is developing a platform called Cchek, a series of non-invasive, blood tests for the early detection of solid tumor based cancers, which is based on the body's immunological response to the presence of a malignancy.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Biological Product (except Diagnostic) Manufacturing

ANIX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
VTI Vanguard Total Stock Market ETF 108.6 B 1.086E+11 3,570 3570 0.0% 0 239 K 238786
VXF Vanguard Extended Market ETF 6.5 B 6.5E+09 3,237 3237 0.0% 1E-05 86 K 86383
ITOT iShares Core S&P Total U.S. Stock Market ETF 21.0 B 2.09757E+10 3,548 3548 0.0% 0 24 K 24154
IWC iShares Microcap ETF 850.6 M 8.50572E+08 1,426 1426 0.02% 0.0002 153 K 153122